The Foundation’s award will support preclinical studies of a potential phage therapy to treat resistant Pseudomonas infections.
Site Search
Showing 1 - 3 of 3 results
News
|
|
2 min read
The Cystic Fibrosis Foundation’s investment will go toward conducting preclinical research on a novel gene delivery vehicle. If successful, this gene delivery method could overcome some of the biggest challenges to delivering a gene therapy into the lung cells of people with cystic fibrosis.
News
|
|
2 min read
The Cystic Fibrosis Foundation is providing up to $5 million to develop a method to deliver a healthy copy of the CFTR gene into the lung cells of people with CF that is unlikely to trigger an immune system response.
News
|
|
4 min read